Highlights

  • Australian Dairy Nutritionals shares rose 4.55% on 21 May 2026 following a funding update.
  • The company secured a $1.5 million secured Loan Facility with RELI Capital Ltd.
  • The facility has a 12-month term and will support Working Capital requirements.
  • The loan is secured against the Group’s Yaringa dairy farm in Victoria.
  • Interest on the facility is set at a variable rate of 9.74% per annum.
  • Management said the funding provides additional stability to pursue FY26 strategy plans.

Australian Dairy Nutritionals Group (ASX:AHF) shares rose 4.55% to AUD 0.023 during the afternoon session on 21 May 2026 after the company announced a new funding arrangement aimed at supporting its operational and working capital requirements. Despite today’s gain, the stock remains down approximately 42.50% over the past year.

Investor attention appeared to focus on the company’s announcement that it had secured a AUD 1.5 million secured loan facility with RELI Capital Ltd, formerly known as Gippsreal Limited.

The funding facility is intended to provide additional financial flexibility for the Group as it continues pursuing its operational strategy for FY26 and beyond.

Australian Dairy Nutritionals stated that the agreement was entered into by its Wholly Owned Subsidiary, Regen Properties Pty Ltd, with the Parent Company acting as guarantor under the arrangement.

The company noted that the borrower is currently working through the remaining conditions precedent required before the first drawdown can occur.

Funding Facility Intended to Support Working Capital

According to the company, the newly secured loan facility will primarily be used for working capital purposes across the Group.

Management described the facility as providing important funding support and operational stability as the Business continues executing its plans during FY26.

The loan facility carries a term of 12 months from the date of the first drawdown and has a maximum borrowing capacity of AUD 1.5 million.

Under the arrangement, an amount equivalent to 12 months of interest at the prevailing variable rate will be retained from the initial drawdown by the lender. That retained amount will then be applied progressively against interest payments due during the term of the facility.

The company indicated that the initial drawdown must occur within four weeks of executing the agreement, subject to completion of several standard conditions precedent.

These conditions include the execution and registration of security documentation, payment of applicable fees and expenses, and obtaining a satisfactory valuation of the secured property.

Security Backed by Dairy Farm Asset

The funding facility is secured against the Group’s Yaringa dairy farm located in Nirranda South, Victoria.

In addition to the property security, the agreement also includes a first-ranking general security over the borrower’s Assets associated with the property.

Australian Dairy Nutritionals Limited has also provided a guarantee and Indemnity in favour of the lender in connection with repayment obligations and performance requirements under the facility agreement.

The structure of the arrangement reflects a typical secured lending framework, particularly for asset-backed working capital funding facilities.

The company also confirmed that RELI Capital Ltd is an independent third-party lender and is neither a related party nor an existing Shareholder.

Interest Rate and Facility Terms Detailed

The announcement outlined several key commercial terms associated with the facility.

The loan carries a Variable Interest Rate of 9.74% per annum, with interest prepaid in advance through the retained amount deducted from the initial drawdown.

However, the agreement also includes a higher default interest mechanism. If an event of default occurs and remains unresolved, the applicable interest rate increases by an additional 6% per annum.

The arrangement also includes an establishment fee of AUD 24,750, including GST.

Another key condition relates to the loan-to-value ratio associated with the secured property. Under the agreement, the loan amount must not exceed 40% of the Market Value of the secured property during the life of the loan.

The company noted that the facility agreement also contains standard commercial terms typically associated with financing arrangements of this nature.

These include repayment obligations, cancellation and termination rights, guarantees and indemnities, representations and warranties, ongoing information undertakings and general operational covenants.

The agreement also contains customary default provisions linked to matters such as non-payment or Insolvency events.

Company Continues Focus on Dairy Operations

Australian Dairy Nutritionals operates as a vertically integrated dairy business with operations spanning dairy farming and processing activities.

The company owns organic and organic A2 protein dairy farms located in southwestern Victoria, an area often referred to as part of Australia’s “Golden Triangle” dairy region.

In addition to farming operations, the Group also operates a processing facility in Camperdown, Victoria.

The company produces the Ocean Road Dairies Organic A2 protein infant formula range, which it describes as Australia’s first organic A2 protein infant formula manufactured using milk sourced from its own organic dairy farms.

The vertically integrated operating structure allows the business to maintain involvement across multiple stages of the dairy production chain, including milk production and infant formula Manufacturing.

The latest funding arrangement appears aimed at supporting ongoing operational continuity while the company continues progressing its broader business strategy.

Market Focus Turns Toward FY26 Stability

While Australian Dairy Nutritionals shares remain below levels seen over the past year, the latest funding announcement may have provided some reassurance to investors regarding short-term Liquidity and operational funding.

Working capital facilities can often play an important role for businesses operating within manufacturing and agricultural sectors, particularly where inventory management, processing activities and production cycles require ongoing funding support.

The facility also appears structured to provide near-term operational stability without immediate Equity dilution.

At the same time, investors are likely to continue monitoring the company’s broader operational performance and strategic execution during FY26.

The market may also focus on how effectively the company utilises the additional funding support while managing operating costs and commercial activities across its dairy and infant nutrition operations.

Loan Facility Aligns with Ongoing Operational Plans

Management stated that the new funding arrangement supports the Group’s strategy not only for FY26 but also beyond the current financial year.

The timing of the facility suggests the company is focused on strengthening its working capital position as it continues operating within the dairy and nutrition sectors.

The Group’s integrated business model, which combines farming and manufacturing operations, can involve substantial operational expenditure requirements linked to production, processing and inventory management.

As a result, maintaining sufficient working capital flexibility can be important in supporting ongoing business continuity.

Although the announcement did not provide specific operational forecasts or Earnings guidance, the secured facility appears intended to support the company’s broader operational objectives while providing additional funding certainty over the next 12 months.

What This Means for Investors

Australian Dairy Nutritionals’ latest update centres on Balance Sheet support and operational funding rather than a direct operational expansion announcement.

The secured AUD 1.5 million loan facility provides the company with additional working capital capacity and may help support business continuity during FY26.

Investors appeared to react positively to the funding update, with shares moving higher during Thursday’s Trading session despite the stock remaining lower over the past 12 months.

The market is likely to continue monitoring how the company progresses operationally following the facility drawdown, particularly across its dairy farming and infant nutrition segments.

Attention may also remain on the company’s ability to manage funding requirements, execute its FY26 strategy and support future operational stability.